XERS
NASDAQ
$8.60
Xeris Biopharma Holdings Inc (XERS)
Xeris Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and markets ready-to-use injectable and infusible drug formulations. The company is headquartered in Chicago, Illinois.
Sector:
Healthcare
Buy
Target: $11.29 (+31.28%)
Market Cap
$1.50B
Revenue 5Y CAGR
+62.01%
Forward P/E
109.89
P/E Ratio
121.84
Price Chart
Valuation
Market Cap$1.50B
P/E121.84
Forward P/E109.89
P/S4.77
P/B109.73
Profitability
Total Revenue (TTM)$315M
Gross Profit (TTM)$270M
EBITDA$37M
Profit Margin2.7%
Operating Margin9.5%
EPS$0.07
Financial Health
Debt-to-Equity1700.3%
Free Cash Flow Yield3.23%
Growth & Risk
Revenue 5Y CAGR+62.01%
Beta (5Y)1.02
Sharpe Ratio1.11